C-terminal interleukin 1 alpha (IL-1α) overexpression drives EMT and a vulnerability to ferroptosis in HNSCC

Read full text
Authors: Ishrat Nourin Khan, Krishna Awasthi, Ziyu Wang, Nafis Md Irfan, Jay Saepoo, Joan N. Whittier, Nurgul Koyuncu, Md Roman Mogal, M.M. Hasibuzzaman, Shujie Yang, Michael S. Petronek, Andrean Llewela Simons‐Burnett
Cited by: 1
References: 75

Abstract

High tumor expression of the cytokine interleukin-1 alpha (IL-1α) is associated with an aggressive tumor phenotype and poor clinical outcomes in head and neck squamous cell carcinoma (HNSCC). However, the mechanism behind IL-1α-induced tumor aggressiveness is unclear. The goal of this work is to investigate the biological consequences of increased IL-1α in HNSCC cells. Three IL1A constructs (Full-length, N-terminal, and C-terminal [CT]) were transduced into Cal27 HNSCC cells and validated for IL-1α expression. Differences in cell survival, metabolic profiling, epithelial-to-mesenchymal transition (EMT), oxidative stress parameters and response to therapy were compared among the parental and IL-1α overexpressing cell lines. Overexpression of CT IL-1α (but not the other constructs) led to increased cell proliferation, membrane fluidity, hydroperoxide production, intracellular iron and lipid peroxidation, EMT changes, and a shift toward glutamate utilization compared to control cell lines. Finally, CT IL-1α cells (but not the other constructs) were highly sensitive to the ferroptosis inducer RSL3. Together this work suggests that increased tumor IL-1α expression triggers a shift toward an oxidative and ferroptotic environment, leading to an aggressive tumor phenotype and drug resistance; but also reveals a unique vulnerability to agents that induce ferroptosis.

Fields of Study & Subjects

Ferroptosis and cancer prognosis Immune cells in cancer Inflammation biomarkers and pathways

Publication details

Journal / source
Redox Biology
Publisher
Elsevier BV
Volume
93
Pages
104172–104172
Publication date
16 April 2026
Language
EN